Market revenue in 2020 | USD 2,043.3 million |
Market revenue in 2028 | USD 3,715.9 million |
Growth rate | 7.8% (CAGR from 2020 to 2028) |
Largest segment | Mental health |
Fastest growing segment | CNS Cancer |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 47.11% in 2020. Horizon Databook has segmented the India central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
India’s CNS therapeutics market is expected to grow at the fastest rate over the forecast period. Increasing prevalence of neurodegenerative & mental health diseases, rising awareness about neurologic conditions, and improvement in healthcare infrastructure are the some of factors driving growth.
Initiatives are being undertaken by government and nongovernment organizations to improve the quality of life of people living with any form of CNS disease. For instance, Alzheimer’s and Related Disorders Society of India (ARDSI) helps patients suffering from serious CNS disorders.
such as Alzheimer’s & Parkinson’s, by providing care, support, and training to patients as well as caregivers. The prevalence of neurological disorders ranged from 967 to 4,070 per 100,000 population in the country. According to an estimate.
Horizon Databook provides a detailed overview of country-level data and insights on the India central nervous system therapeutic market , including forecasts for subscribers. This country databook contains high-level insights into India central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account